Table III.
Society, year of publication | RBC transfusion threshold | Clinical setting | Grading of evidence1 | Ref. |
---|---|---|---|---|
College of American Pathologists, 1998 | Hb level <6 g/dL | Acute anaemia in surgical and non-surgical patients | NA | 33 |
Society of Critical Care Medicine (SCCM), 2009 | Hb level <7 g/dL | Critically ill patients | NA | 34,35 |
American Academy of Family Physicians, 2011 | Hb level <7 g/dL | The threshold for transfusion of RBC should be a Hb level of 7 g/dL in adults and most children. | A | 36 |
Hb level between 7–9 g/dL | A restrictive transfusion strategy should not be used in preterm infants or children with cyanotic heart disease, severe hypoxaemia, active blood loss, or haemodynamic instability. | B | ||
Society of Thoracic Surgeons, Society of Cardiovascular Anesthesiologists (SCA), 2007; and 2011 Guidelines Update | Hb level <7 g/dL | Cardiac surgery | C, Class IIa | 37,38 |
Italian Society of Transfusion Medicine and Imunohematology (SIMTI), 2011 | Hb level <6 g/dL | Intra- or post-operative period | 1C+ | 39,40 |
Hb level between 6–10 g/dL | Presence of risk factors (i.e., CAD, heart failure, CVD) or symptoms indicative of hypoxia | 1C+, 2C | ||
European Society of Cardiology (ESC), 2011 | Compromised haemodynamic status or Hb level <7 g/dL (Target Hb level of 9–10 g/dL) or haematocrit <25% | Anemic patients with ACS | B, Class I | 41 |
American College of Gastroenterology (ACG), 2012 | Hb level <7 g/dL | Patients with upper gastrointestinal bleeding. Blood transfusions should target Hb level ≥7 g/dL, with higher Hb targeted in patients with clinical evidence of intravascular volume depletion or comorbidities such as coronary artery disease. | Conditional recommendation, low-to-moderate-quality evidence | 42 |
National Blood Authority. Patient blood management guidelines: Module 2 - Perioperative. Australia, 2012 | Hb level <8 g/dL | In the absence of acute myocardial or cerebrovascular ischaemia, postoperative transfusion may be inappropriate for patients with a Hb level >8 g/dL. | NA | 43 |
National Blood Authority. Patient blood management guidelines: Module 3 - Medical. Australia, 2012 | Hb level <7 g/dL | Medical conditions | NA | 43 |
Hb level <8 g/dL | Patients with ACS | NA | ||
National Blood Authority. Patient blood management guidelines: Module 4 - Critical Care. Australia, 2013 | Hb level <7 g/dL | Critical care | NA | 43 |
European Society of Anaesthesiology (ESA), 2017 | Maintain Hb between 7–9 g/dL | Active bleeding | 1C | 44 |
Maintain Hb between 7–9 g/dL | No active bleeding | 1A | ||
Seville Document, 2013 (six Spanish scientific societies) | Maintain Hb between 7–9 g/dL | Non bleeding critically ill patients, trauma and/or surgical patients, without cardiac and/or central nervous system dysfunction | 1A | 45 |
Maintain Hb between 8–10 g/dL | Non bleeding critically ill patients, trauma and/or surgical patients, with cardiac and/or central nervous system dysfunction | 1A | ||
American College of Physicians, 2013 | Hb level between 7–8 g/dL | Hospitalised patients with coronary heart disease | Weak recommendation; low-quality evidence | 46 |
British Committee for Standards in Hematology (BCSH), 2013 | Hb level ≤7 g/dL | Critically ill patients (target: Hb level 7–9 g/dL). Transfusion triggers should not exceed 9 g/dL in most critically ill patients (grade 1B). | 1B | 47 |
NCCN Guidelines Version 2.2014 Cancer- and Chemotherapy- Induced Anemia. NCCN Clinical Practice Guidelines in Oncology. Fort Washington, PA: National Comprehensive Cancer Network, 2013 | Hb level between 7–9 g/dL | Haemodynamically stable chronic anaemia without ACS | 2A | 48 |
Hb level between 8–10 g/dL | Symptomatic anaemia | 2A | ||
Hb level between >10 g/dL | Anaemia with ACS or acute myocardial infarction | 2A | ||
The National Institute for Health and Care Excellence (NICE) Acute upper gastrointestinal bleeding, 2014 | Hb level <7 g/dL | Patients with upper gastrointestinal bleeding. The strategy of providing blood transfusion when the patient’s haemoglobin drops to a lower threshold (7 g/dL) may be associated with lower mortality and fewer adverse events than transfusion at a higher threshold (9 g/dL) | Low | 49 |
American Society of Anestesiologists, 2015 | Hb level <6 g/dL | Perioperative blood management | NA | 50 |
The National Institute for Health and Care Excellence (NICE) blood transfusion guideline NG24, 2015 | Hb level ≤7 g/dL | Hb level ≤8 g/dL (target: Hb 8–10 g/dL after transfusion) for patients with ACS. Individual thresholds and Hb concentration targets for each patient who needs regular blood transfusions for chronic anaemia. |
NA | 51 |
UK National Clinical Guideline Centre (NCGC), 2015 | Hb level <7 g/dL | Hb level >7 g/dL (target: Hb 7–9 g/dL) | NA | 52 |
Hb level <8 g/dL | ACS need regular blood transfusions for chronic anaemia (target: Hb 8–10 g/dL) | NA | ||
Recommendations from the College of Intensive Care Medicine & the Australian and New Zealand Intensive Care Society on end-of-life care, invasive devices, anaemia, sedation & antibiotics, 2016 | Hb level <7 g/dL | Transfuse red cells for anaemia only if the Hb level <7 g/dL or if the patient is haemodynamically unstable or has significant cardiovascular or respiratory comorbidity. |
NA | 53 |
AABB (formerly American Association of Blood Banks), 2016 | Hb level <7 g/dL | Hospitalised adult patients who are haemodynamically stable, including critically ill patients | Strong recommendation, moderate quality evidence | 54 |
Hb level <8 g/dL | Patients undergoing orthopaedic surgery or cardiac surgery and patients with preexisting cardiovascular disease | Strong recommendation, moderate quality evidence |
For the interpretation of the various grades of recommendations and levels of evidence, see material and methods of the related references.
Hb: haemoglobin; NA: not available; CAD: coronary artery disease; ACS: acute coronary syndrome; CVD: cardiovascular disease.